IL6 and atherosclerosis: Long-term average IL-6 has proven to be a predictor of progression of carotid atherosclerosis, independent of conventional vascular risk factors, suggesting that IL-6 could be a marker and a therapeutic target for accelerated atherosclerosis [78].